Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511

NCT04327011 is registered in ClinicalTrials.gov with Tocagen Inc. as lead sponsor.

NCT NCT04327011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04327011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511
Lead sponsor
Tocagen Inc.
Phase
Phase 1
Overall status
Terminated
Start date
February 28, 2011
Completion date
December 31, 2019
Enrollment
65 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

astrocytoma, glioblastoma multiforme, gliomas, malignant